Nvision Biomedical Technologies, Inc.

Nvision Biomedical Technologies is a San Antonio-based medical device and biologics company founded in 2013, specializing in orthopedic implants and biologics for surgeons. The company leverages more than 100 years of combined industry experience to develop products that simplify and improve surgical procedures. Nvision's product portfolio spans spine, extremities, and biologics categories, with a focus on providing treatment options where orthopedic implant devices are indicated. The company operates multiple brands including Boundary, Focus, Healix, Javelin, Forma, Vertex, Tangis, Vector, and Radian. Notable products include the Nvision Activate (full-thickness placental-derived allograft), Nvision Quantum (anterior cervical plate), and Nvision Trigon (osteotomy wedge system). Nvision also maintains involvement in wound care and diabetic foot ulcer research through affiliated entities such as Sequence LifeScience, Inc., which is conducting clinical trials for diabetic foot ulcer treatment. The company is committed to meeting customer needs with high-quality medical products meeting regulatory and clinical standards for orthopedic surgical applications. Manufacturing and regulatory credentials are not explicitly detailed on the website, though the company's portfolio suggests FDA clearance for marketed devices.